Dr Faraidoon Haghdoost Explains Results of COVID-19 Migraine Triggers, Frequency Study

October 28th 2020, 1:00pm


There can be a myriad of reasons for the patterns observed in our study on alteration of migraine frequency and triggers during the pandemic, said Faraidoon Haghdoost, MD, a general practitioner and PhD student at The George Institute for Global Health in Sydney, Australia.

Researchers Show Brain Differences in 2 Different Types of Menstrual Migraine

October 26th 2020, 9:30pm


In a study published in Scientific Reports, researchers highlighted structural and functional brain differences among those who suffer menstrual-related migraine (MRM) and pure menstrual migraine (PMM).

Dr Peter McAllister on How COVID-19 Has Impacted Migraine Prevention Efforts

October 22nd 2020, 1:00pm


Increased time spent in front of computer screens, less time spent sleeping, and less access to gyms have led my patients to have a lot more migraines, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.

Dr Messoud Ashina Talks Through the 5-Year Safety and Efficacy Data on Erenumab

October 19th 2020, 6:40pm


Data from a 5-year open-label treatment period on the safety profile of erenumab (Aimovig) showed the treatment helped patients with episodic migraine achieve a sustained reduction in the number of monthly migraine days and the number of days in which therapies were needed for acute migraines.

Study Describes Relationship Between Migraine, Postoperative Nausea and Vomiting

October 14th 2020, 3:00pm


Migraine is a significant risk factor for postoperative nausea and vomiting, according to results of a retrospective study published in the Journal of Clinical Medicine.

Dr Rigmor Jensen Discusses Prevalence of Medication Overuse Headache

October 13th 2020, 1:00pm


Medication overuse headache is a huge problem in societies that don't have access to proper headache care as patients take more over-the-counter, readily available treatments, said Rigmor Jensen, MD, professor of neurology at The University of Copenhagen and director of the Danish Headache Center.

Smartphone App Unable to Accurately Predict Episodic Migraine

October 7th 2020, 4:59pm


In an attempt to develop a multivariable predictive model for days with new-onset migraine headaches, researchers found episodic migraine attacks were not predictable based on self-prediction or on self-reported exposure to common trigger factors.

Report Details Need for Treatment Guidelines on Comorbid Migraine, Major Depressive Disorder

October 6th 2020, 3:15pm


Treatment guidelines for comorbid depression and migraine are warranted to ensure optimal efficacy and avoid possible pitfalls in psychopharmacotherapy, according to study results.

Study Finds GONB With Bupivacaine Inferior to IV Metoclopramide as First-line Treatment for Migraine

September 30th 2020, 5:40pm


According to a study published in Headache, greater occipital nerve blocks (GONB) with bupivacaine were not as effective as intravenous (IV) metoclopramide as a first-line treatment for migraineurs who presented to emergency departments.

Study Examines Relationship Between Sexual Orientation, Migraine Prevalence

September 28th 2020, 8:15pm


New research published in JAMA Neurology highlights disparities in migraine based on sexual orientation in the United States.